Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia [Phase 1]
Phase 1 safety and tolerability update for Lu AF35700 in schizophrenia patients following repeated dosing.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167 [Phase 1]
Phase 1 pharmacokinetic study evaluating various modified-release tablet formulations of Lu AF11167; the trial has completed in participants…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Bioavailability of LY03004 and Risperdal® Consta® [Phase 1]
Phase 1 study evaluating the bioavailability of LY03004 relative to Risperdal Consta (paliperidone palmitate) has been completed. The trial …
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders [EARLY_Phase 1]
An early Phase 1 trial evaluating a dopamine D1 receptor agonist for cognitive enhancement in schizophrenia and schizoaffective disorder has…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: Metacognitive Training in Schizophrenia [NA]
A completed clinical trial evaluating metacognitive training for schizophrenia, including delusions, is reported. The study was sponsored by…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: The Effects of Rimonabant, on Weight and Metabolic Risk Factors [Phase 2]
Phase 2 trial investigating the effects of rimonabant on weight and metabolic risk factors; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: Pharmacokinetic Study of MIN-101 in Healthy Subjects [Phase 1]
Minerva Neurosciences completed a Phase 1 pharmacokinetic study of MIN-101 in healthy subjects, outlining basic PK parameters.
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of multiple doses of ITI-214 in healthy adults and in adults with stable schizophre…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics [Phase 3]
Phase 3 trial comparing injectable paliperidone palmitate with oral antipsychotics for relapse prevention in schizophrenia; the study is com…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia [Phase 4]
A Phase 4 clinical trial update evaluating the efficacy of omega-3 fatty acids in individuals with first-episode schizophrenia; current stat…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of Lu AF11167 after repeated dosing in patients with schizophrenia; the study has c…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia [NA]
This clinical trial update notes the completion of a study examining how repetitive transcranial magnetic stimulation affects serum brain-de…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia [Phase 3]
Phase 3 trial update reports results for aripiprazole intramuscular depot (OPC-14597 / Lu AF41155) in the acute treatment of adults with sch…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Clinical Estradiol Trial in Women With Schizophrenia [Phase 2]
A Phase 2 clinical trial of estradiol in women with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial exploring selective estrogen receptor modulators as a potential treatment for psychotic symptoms in schizophrenia; th…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 2]
Phase 2 clinical trial update for RP5063 in schizophrenia and schizoaffective disorder. The study completed and results were posted in Janua…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia [Phase 4]
A Phase 4 trial assessing the effectiveness and safety of amisulpride in Chinese patients with schizophrenia has been completed and results …
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox [Phase 2]
A Phase 2 clinical trial update reporting completion of a study evaluating how treatment interruption affects re-initiation of bifeprunox in…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Bifeprunox in the Treatment of Schizophrenia [Phase 3]
The Phase 3 clinical trial evaluating bifeprunox for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia [Phase 2]
Phase 2 study evaluating twice-daily titration of bifeprunox in schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder [Phase 2]
Phase 2 trial update examining progressively decreasing titration schedules of bifeprunox in individuals with schizophrenia or bipolar disor…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Nicotine Effects on Endophenotypes of Schizophrenia [NA]
A completed clinical trial evaluating nicotine effects on endophenotypes in schizophrenia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics [Phase 1]
Phase 1 study evaluating safety, tolerability, PK and PD of EVP-6308 and its potential to affect the PK of concomitant antipsychotic therapy…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness [NA]
Clinical trial update on the In SHAPE fitness intervention for adults with serious mental illness indicates the study status is COMPLETED. T…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI [NA]
This ClinicalTrials.gov update reports that the statewide program to prevent early mortality and promote fitness in persons with serious men…